Major peptide autoepitopes for nucleosome-specific T cells of human lupus

Journal of Clinical Investigation

Volumn 104, Issue 3, 1999, Pages 345-355

  Lu, Liangjun ^a   Kaliyaperumal, Arunan ^a   Boumpas, Dimitrios T ^b   Datta, Syamal K ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNITY; HELPER CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LUPUS ERYTHEMATOSUS; NUCLEOSOME; PRIORITY JOURNAL;

EID: 0032728568     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI6801     Document Type: Article

References (50)

1. Shivakumar, S., Tsokos, G.C, and Datta, S.K. 1989. T cell receptor α/β expressing double negative (CD4-/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis. J. Immunol. 143:103-112.
2. Rajagopalan, S., Zordan, T., Tsokos, G.C, and Datta, S.K. 1990. Pathogenic anti-DNA autoantibody inducing T helper cell lines from patients with active lupus nephritis: isolation of CD4-/CD8- T helper cell lines that express the gamma/δ T-cell receptor. Proc. Natl. Acad. Sci. USA. 87:7020-7024.
3. Desai-Mehta, A., Mao, C., Rajagopalan, S., Robinson, T.,and Datta, S.K. 1995. Structure and specificity of T-cell receptors expressed by pathogenic anti-DNA autoantibody-inducing T cells in human lupus. J. Clin. Invest. 95:531-541.
4. A. Sainis, K., and Datta, S.K. 1988. CD4+ Tcell lines wich selective patterns of autoreactivity as well as CD4-/CD8- T helper cell lines augment the production of idiotypes shared by pathogenic anti-DNA autoanribodies in the NZB × SWR model of lupus nephritis. J. Immunol. 140:2215-2224.
5. Adams, S., Leblanc, P., and Datta, S.K. 1991. Junctional region sequences of T-cell receptor β chain genes expressed by pathogenic anti-DNA autoantibody-inducing T helper cells from lupus mice: possible selection by cationic autoantigens. Proc. Natl. Acad. Sci. USA. 88:11271-11275.
6. Mohan, C., Adams, S., Stanik, V., and Datta, S.K. 1993. Nucleosome: a major immunogen for the pathogenic autoantibody-inducing T cells of lupus. J. Exp. Med. 177:1367-1381.
7. Kaliyaperumal, A., Mohan, C., Wu, W., and Datta, S.K. 1996. Nucleosomal peptide epitopes for nephritis-inducing T helper cells of murine lupus. J. Exp. Med. 183:2459-2469.
8. Voll, R.E., et al. 1997. Historic-specific Th0 and Th 1 clones derived from systemic lupus erythematosus patients induce double-stranded DNA antibody production. Arthritis Rheum. 40:2162-2171.
9. Kramers, C., et al. 1994. Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo. J. Clin. Invest. 94:568-577.
10. Burlingame, R.W., Boey, M.L., Starkebaum, G., and Rubin, R.L. 1994. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J. Clin. Invest. 94:184-192.
11. Bernstein, K.A., DiValerio, R., and Lefkowith, J.B. 1995. Glomerular binding activity in MRL 1pr serum consists of antibodies that bind to a DNA/histone/type IV collagen complex. J. Immunol. 154:2424-2433.
12. Chabre, H., et al. 1995. Presence of nucleosome-restricted antibodies in patients with systemic lupus erythematosus. Arthritis Rheum. 38:1485-1491.
13. Casciola-Rosen, L.A., Anhalt, G., and Rosen, A. 1994. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179:1317-1330.
14. Mevorach, D., Zhou, J.L., Song, X., and Elkon, K.B. 1998. Systemic exposure to irradiated apoptotic cells induces autoantibody production. J. Exp. Med. 188:387-392.
15. Ray, S.K , Putterman, C., and Diamond, B. 1996. Pathogenic autoantibodies are routinely generated during the response to foreign antigen: a paradigm for autoimmune disease. Proc. Natl. Acad. Sci USA. 93:2019-2024.
16. Mohan, C., Shi, Y., Laman, J.D., and Datta, S.K. 1995. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J. Immunol. 154:1470-1480.
17. Desai-Mehta, A., Lu, L., Ramsey-Goldman, R., and Datta, S.K. 1996. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J. Clin. Invest. 97:2063-2073.
18. Liang, M.H., Socher, S.A., Larson, M.G., and Schur, P.H 1989. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum. 32:1107-1118.
19. Waldrop, S.L., Pitcher, C.J., Peterson, D.M., Maino, V.C., and Picker, L.J. 1997. Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry. J. Clin. Invest. 99:1739-1750.
20. Openshaw, P., et al. 1995. Heterogeneity of intracellular cytokine synthesis at single-cell level in polarized T helper 1 and T helper 2 populations. J. Exp. Med. 182:1357-1367.
21. Estcourt, C., et al. 1997. Flow cytometric assessment of in vivo cytokine-producing monocytes in HIV-infected patients. Clin. Immunol. Immunopathol. 83:60-67.
22. Shi, Y., et al. 1998. Promiscuous presentation and recognition of nucleosomal autoepitopes in lupus: role of autoimmune T cell receptor alpha chain. J. Exp. Med. 187:367-378.
23. Kaliyaperumal, A., Michaels, M.A., and Datta, S.K. 1999. Antigen-specific therapy of murine lupus nephritis using nucleosomal peptides: tolerance spreading impairs pathogenic function of autoimmune T and B cells. J. Immunol. 162:5775-5783.
24. Bieganowska, K.D., et al. 1997. Direct ex vivo analysis of activated, Fassensitive autoreactive T cells in human autoimmune disease. J. Exp. Med. 185:1585-1594.
25. Gavalchin, J., and Datta, S.K. 1987. The NZB × SWR model of lupus nephritis. II. Autoantibodies deposited in renal lesions show a restricted idiotypic diversity. J. Immunol. 138:138-148.
26. Peng, S.L., Moslehi, J., and Craft, J. 1997, Roles ofinterferon-gamma and interleukin-4 in murine lupus. J. Clin. Invest. 99:1936-1946.
27. Balomenos, D., Rumold, R., and Theofilopoulos, A.N. 1998. Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-1pr mice. J. Clin. Invest. 101:364-371.
28. Tao, X., Constant, S., Jorritsma, P., and Bottomly, K. 1997. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation. J. Immunol. 159:5956-5963.
29. Linker-Israeli, M. 1992. Cytokine abnormalities in human lupus. Clin. Immunol. Immunopathol. 63:10-12.
30. Ishida, H., et al. 1994. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J. Exp. Med. 179:305-310.
31. Llorente, L., et al. 1995. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of systemic lupus erythematosus. J. Exp. Med. 181:839-844.
32. Nakajima, A., Hiroshe, S., Yagita, H., and Okomura, K. 1997. Roles of IL-4 and IL-12 in the development of lupus in NZB/W F1 mice. J. Immunol. 158:1466-1472
33. Yung, R., et al. 1996. Mechanisms of drug-induced lupus. II. T cells over-expressing lymphocyte function-associated antigen 1 become autoreactive and cause a lupus like disease in syngeneic mice. J. Clin. Invest. 97:2866-2871.
34. Craft, J., and Fatenejad, S. 1997. Self antigens and epitope spreading in systemic autoimmunity. Arthritis Rheum. 40:1374-1382.
35. Wucherpfennig, K., and Strominger, J.L. 1995. Molecular mimicry in T cell mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell. 80:695-705.
36. Evabold, B.D., et al. 1995. Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands. Immunity. 2:655-663.
37. Bhardwaj, V., Kumar, V., Geysen, H.M., and Sercarz, E.E. 1993. Degenerate recognition of a dissimilar antigenic peptide by myelin basic protein-reactive T cells. J. Immunol 151:5000-5010.
38. Mason, D. 1998. A very high level of crossreactivity is an essential feature of the T-cell receptor, Immunol. Today. 19:395-404.
39. Hemmer, B., et al. 1998. Predictable TCR antigen recognition based on peptide scans leads to the identification of agonist ligands with no sequence homology. J. Immunol. 160:3631-3636.
40. Singh, R.R., Hahn, B.H., Tsao, B.P., and Ebling, F.M. 1998. Evidence for multiple mechanisms of polyclonal T cell activation in murine lupus. J. Clin. Invest. 102:1841-1849.
41. Kuchroo, V.K., et al. 1994. A single TCR antagonist peptide inhibits experimental allergic encephalomyelitis mediated by a diverse TCR repertoire. J. Immunol. 153:3326-3336.
42. Garcia, K.C., et al. 1998. Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science. 279:1166-1172.
43. Stemmer, C., Briand, J.-P., and Muller, S. 1997. Mapping of linear histone regions exposed at the surface of the nucleosome in solution. J. Mol. Biol. 273:52-60.
44. Monestier, M., and Kotzin, B.L 1992. Antibodies to histones in systemic lupus erythematosus and drug-induted lupus syndromes. Rheum. Dis. Clin. North Am. 18:415-436.
45. Stemmer, C., et al. 1996. Dual reactivity of several monoclonal anti-nucleosome antibodies for double stranded DNA and a short segment of histone H3. J. Biol Chem. 271:21257-21261.
46. Vyse, T.J., and Kotzin, B.L. 1998. Genetic susceptibility to systemic lupus erythematosus. Anna. Rev. Immunol. 16:261-292.
47. Morel, L., and Wakeland, E.K. 1998. Susceptibility to lupus nephritis in the NZB/NZW model system. Curr. Opin. Immunol. 10:718-725.
48. Southwood, S., et al. 1998. Several common HLA-DR types share largely overlapping peptide binding repertoires. J. Immunol. 160:3363-3373.
49. Chicz, R.M., et al. 1993. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 178:27-47.
50. Chicz, R.M., et al. 1992. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature. 358:764-768.